Deutsche Bank Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $85
Deutsche Bank Sticks to Its Buy Rating for Edwards Lifesciences (EW)
Baird Adjusts Edwards Lifesciences Price Target to $70 From $68, Maintains Neutral Rating
Morgan Stanley Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Cuts Target Price to $46
Edwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell Rating
Bernstein Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Announces Target Price $73
BofA Securities Upgrades Edwards Lifesciences(EW.US) to Buy Rating, Raises Target Price to $90
BofA Securities Upgrades Edwards Lifesciences to Buy From Neutral, Price Target Is $90
Is It Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
Citi Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $83
Express News | Edwards Lifesciences Corp : Citigroup Raises Target Price to $83 From $81
Truist Financial Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $78
Edwards Lifesciences Insider Sold Shares Worth $358,751, According to a Recent SEC Filing
Edwards Lifesciences Insider Sold Shares Worth $806,406, According to a Recent SEC Filing
Is Now An Opportune Moment To Examine Edwards Lifesciences Corporation (NYSE:EW)?
Is Edwards Lifesciences Stock Underperforming the S&P 500?
Be Wary Of Edwards Lifesciences (NYSE:EW) And Its Returns On Capital
A Quick Look at Today's Ratings for Edwards Lifesciences(EW.US), With a Forecast Between $75 to $90
Oppenheimer Remains a Buy on Edwards Lifesciences (EW)
Edwards Lifesciences (EW) Receives a Buy From RBC Capital